In addition, overexpression of SREBP1 in leptin-diminished NPC cells reversed shleptin-inhibited tumor proliferation in vitro and in vivo as well as the intracellular TG, cholesterol, and phospholipid levels, indicating that leptin induced tumor growth and lipid metabolism are required for SREBP1 expression. This evidence concerns the gene LEP and neoplasm.